The FDA approved Amgen’s cholesterol-lowering drug on Thursday, teeing up a rivalry with a similar treatment that was approved just weeks earlier.
Fda Approves Amgen's Cholesterol Drug
WSJ.com: US Business, Wall Street Journal: Business
Thu, 08/27/2015 - 4:33pm
BING NEWS:
- Amgen’s costly, highly toxic cancer dosing continues despite feds' challenge
The FDA told Amgen to test whether a quarter-dose of sotorasib worked as well as the amount on the label. It did, but the biotech is sticking to the higher dose, which earns it an extra $180,000 a ...
05/7/2024 - 6:52 am | View Link - Amgen's new Horizon products bolster top line despite continued Tepezza struggles
During the Q&A portion of Amgen’s quarterly conference call Thursday, eight of the first nine questions were about the company’s investigational efforts in obesity. | The buzz about Amgen’s obesity ...
05/3/2024 - 2:05 am | View Link - Coming FDA Approvals Could Send These 3 Drug Stocks Soaring
As with most drug stocks of Amgen’s size, revenue growth has slowed but ... a lower multiple than both Merck and Amgen. If the FDA approves Libervant for toddlers, it could easily become the ...
04/17/2024 - 1:09 am | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more